Amarantus Bioscience Holdings Inc (AMBS)

[zoomboom]

MILESTONES

In the last year the AMBS has achieved the following important milestones:

Entered the public markets and significantly expanded our shareholder base;
Confirmed efficacy of our MANF Program in Parkinson's disease;
Received grant funding to initiate our MANF Program in Traumatic Brain Injury.

The most critical milestones for us to achieve in the next 12 months are:

Raising sufficient capital to efficiently fund our therapeutic and diagnostic programs; (Money is coming in)
Advancing our various product development programs to key value inflexion milestones;
Finalizing the business development transactions executed over the past 12 months;
Recruiting seasoned product development expertise in the areas of biopharmaceutical and diagnostic product development; ( DONE )
Listing our common stock on a national stock exchange. ( ON our way)


source:
http://www.amarantus.com/